ANDREW BADACHHAPE to Mice
This is a "connection" page, showing publications ANDREW BADACHHAPE has written about Mice.
Connection Strength
0.382
-
Ferumoxytol-enhanced MRI of retroplacental clear space disruption in placenta accreta spectrum. Placenta. 2025 02; 160:100-106.
Score: 0.065
-
Nanoparticle Contrast-enhanced MRI for Visualization of Retroplacental Clear Space Disruption in a Mouse Model of Placental Accreta Spectrum (PAS). Acad Radiol. 2023 Jul; 30(7):1384-1391.
Score: 0.056
-
Pre-clinical dose-ranging efficacy, pharmacokinetics, tissue biodistribution, and toxicity of a targeted contrast agent for MRI of amyloid deposition in Alzheimer's disease. Sci Rep. 2020 09 30; 10(1):16185.
Score: 0.049
-
Nanoparticle Contrast-enhanced T1-Mapping Enables Estimation of Placental Fractional Blood Volume in a Pregnant Mouse Model. Sci Rep. 2019 12 10; 9(1):18707.
Score: 0.046
-
Pre-clinical magnetic resonance imaging of retroplacental clear space throughout gestation. Placenta. 2019 02; 77:1-7.
Score: 0.043
-
Biodegradable nanofibrous drug-eluting seed for sustained intratumoral immunotherapy. J Control Release. 2026 07 10; 395:115004.
Score: 0.018
-
Nano-radiomics of molecular MRI for early amyloid associated patterns in an Alzheimer's disease mouse model via an automatic pipeline. BMC Med Imaging. 2026 04 10; 26(1).
Score: 0.018
-
Dinaciclib improves treatment response in chemoresistant hepatoblastoma. Sci Rep. 2025 Dec 05; 16(1):1410.
Score: 0.017
-
A novel treatment strategy utilizing panobinostat for high-risk and treatment-refractory hepatoblastoma. J Hepatol. 2024 04; 80(4):610-621.
Score: 0.015
-
Rational Design of a Self-Assembling High Performance Organic Nanofluorophore for Intraoperative NIR-II Image-Guided Tumor Resection of Oral Cancer. Adv Sci (Weinh). 2023 04; 10(10):e2206435.
Score: 0.014
-
HepT1-derived murine models of high-risk hepatoblastoma display vascular invasion, metastasis, and circulating tumor cells. Biol Open. 2022 09 15; 11(9).
Score: 0.014
-
A surrogate marker for very early-stage tau pathology is detectable by molecular magnetic resonance imaging. Theranostics. 2022; 12(12):5504-5521.
Score: 0.014
-
MDM4 inhibition: a novel therapeutic strategy to reactivate p53 in hepatoblastoma. Sci Rep. 2021 02 03; 11(1):2967.
Score: 0.012